Literature DB >> 3280311

Structural studies on the core and lipid A region of a 4-amino-L-arabinose-lacking Rc-type mutant of Proteus mirabilis.

J Radziejewska-Lebrecht1, U R Bhat, H Brade, H Mayer.   

Abstract

The structure of the 4-amino-L-arabinose-lacking lipopolysaccharide of the Proteus mirabilis Rc-type mutant R4, derived from wild-type O28, was elucidated. The lipopolysaccharide core structure has previously been partially characterized. The linkage between heptose and deoxyoctulosonic acid(dOclA) is now reported, as well as the structure of the lipid A moiety of this mutant strain. Besides the tentative identification of an alpha-linked glucosamine disaccharide in the lipid A backbone accompanying the usual beta 1----6-linked glucosamine-disaccharide, the only significant structural variation to previous studies was the lack of substitution of the C-4' phosphate by 4-amino-L-arabinose. In addition, the substitution at C-8 of one dOclA unit by 4-amino-L-arabinose, previously reported for the R45 mutant of P. mirabilis 1959, is lacking in this R mutant. Also in addition to previous findings, the terminal unit of heptose was found to be substituted at C-7 with phosphorylethanolamine (PEtN) and not only with phosphate, although this substitution is not complete as demonstrated by the relevant signals in 31P-NMR. Additional studies with the wild-type strain P. mirabilis O28 revealed the presence of 4-amino-L-arabinose in both the core and the lipid A regions suggesting that the R4 mutant is defective in the biosynthesis of this amino sugar rather than in its transfer. Otherwise the lipid A regions of the mutant and the wild-type strain show no structural differences. The following formula is proposed for the lipopolysaccharide of 4-amino-L-arabinose-lacking mutant R4/O28 P. mirabilis: (Formula; see text)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3280311     DOI: 10.1111/j.1432-1033.1988.tb13922.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  5 in total

Review 1.  Immunoprophylaxis and immunotherapy of gram-negative sepsis and shock with antibodies to core glycolipids and lipid A of bacterial lipopolysaccharides.

Authors:  I G Mitov; D G Terziiski
Journal:  Infection       Date:  1991 Nov-Dec       Impact factor: 3.553

2.  Novel modification of lipid A of Francisella tularensis.

Authors:  Nancy J Phillips; Birgit Schilling; Molly K McLendon; Michael A Apicella; Bradford W Gibson
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

3.  Unusual interaction of a lipopolysaccharide isolated from Burkholderia cepacia with polymyxin B.

Authors:  Hirofumi Shimomura; Motohiro Matsuura; Shinji Saito; Yoshikazu Hirai; Yasunori Isshiki; Kazuyoshi Kawahara
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

4.  Unique ability of the Proteus mirabilis capsule to enhance mineral growth in infectious urinary calculi.

Authors:  A J Dumanski; H Hedelin; A Edin-Liljegren; D Beauchemin; R J McLean
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

5.  ECA-immunogenicity of Proteus mirabilis strains.

Authors:  Katarzyna Anna Duda; Katarzyna Teresa Duda; Agnieszka Beczała; Katarzyna Kasperkiewicz; Joanna Radziejewska-Lebrecht; Mikael Skurnik
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2009-03-31       Impact factor: 4.291

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.